Literature DB >> 10917215

Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.

P Toikka1, K Irjala, T Juvén, R Virkki, J Mertsola, M Leinonen, O Ruuskanen.   

Abstract

OBJECTIVE: Serum procalcitonin (PCT), C-reactive protein (CRP) and interleukin-6 (IL-6) concentrations were measured in 126 children hospitalized for community-acquired, radiologically confirmed pneumonia to assess whether these host response values could be used to distinguish bacterial from viral pneumonia.
METHODS: The samples for PCT, CRP and IL-6 measurements were obtained on admission or the first day of hospitalization. The etiology of pneumonia was studied with an extensive panel of methods that detected 6 bacteria and 11 viruses.
RESULTS: In all, 54% had evidence of bacterial pneumonia, and 32% had evidence of sole viral pneumonia. In 14% of the cases the etiology could not be determined. Children with bacterial pneumonia had significantly higher PCT (median 2.09 ng/ml vs. 0.56 ng/ml, P = 0.019) and CRP concentrations (96 mg/l vs. 54 mg/l, P = 0.008) than those with sole viral etiology. However, the values markedly overlapped. No significant difference in IL-6 concentrations was seen between the two patient groups. Using PCT > or = 2.0 ng/ml, CRP > or = 150 mg/l or IL-6 > or = 40 pg/ml, the specificity was > or =80% for bacterial pneumonia. The sensitivities with these cutoff values were 50% for PCT, 31% for CRP and 34% for IL-6.
CONCLUSIONS: The results indicate that the measurement of serum PCT, CRP and IL-6 has little value in the differentiation of bacterial and viral pneumonia in children. However, in some patients with very high serum PCT, CRP or IL-6 values, bacterial pneumonia is probable.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10917215     DOI: 10.1097/00006454-200007000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  56 in total

1.  Value of monitoring serum procalcitonin in neonates at risk of infection.

Authors:  M M Koskenvuo; K Irjala; A Kinnala; O Ruuskanen; P Kero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-16       Impact factor: 3.267

2.  BTS guidelines for the management of pleural infection in children.

Authors:  I M Balfour-Lynn; E Abrahamson; G Cohen; J Hartley; S King; D Parikh; D Spencer; A H Thomson; D Urquhart
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

Review 3.  Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

Authors:  Victor van der Meer; Arie Knuistingh Neven; Peterhans J van den Broek; Willem J J Assendelft
Journal:  BMJ       Date:  2005-06-24

4.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

5.  Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children?

Authors:  Dilshad Ahmad Khan; Aisha Rahman; Farooq Ahmad Khan
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 6.  Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.

Authors:  Matti Korppi
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis.

Authors:  K Thorburn; S Harigopal; V Reddy; N Taylor; H K F van Saene
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

8.  C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department.

Authors:  Yael Paran; Doron Yablecovitch; Guy Choshen; Ina Zeitlin; Ori Rogowski; Ronen Ben-Ami; Michal Katzir; Hila Saranga; Tovit Rosenzweig; Dan Justo; Yaffa Orbach; Pinhas Halpern; Shlomo Berliner
Journal:  Crit Care       Date:  2009-04-08       Impact factor: 9.097

Review 9.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

10.  Community-acquired pneumonia in children.

Authors:  H Dele Davies
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.